Carl Turesson Selected Research

Rheumatoid Vasculitis

1/2009	Vasculitis in rheumatoid arthritis.
1/2005	The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis.
5/2004	Management of extra-articular disease manifestations in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carl Turesson Research Topics

Disease

27	Rheumatoid Arthritis 01/2022 - 05/2004
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 01/2004
4	Inflammation (Inflammations) 11/2022 - 11/2014
4	Giant Cell Arteritis (Horton Disease) 01/2021 - 01/2016
3	Arthritis (Polyarthritis) 01/2021 - 05/2015
3	Necrosis 01/2016 - 05/2007
3	Vasculitis (Vasculitides) 01/2009 - 05/2004
3	Rheumatoid Vasculitis 01/2009 - 05/2004
2	Osteoporosis 11/2022 - 01/2021
2	Fever (Fevers) 11/2022 - 01/2016
2	Joint Diseases (Joint Disease) 12/2021 - 01/2021
2	COVID-19 12/2021 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2004
2	Pain (Aches) 01/2021 - 01/2020
2	Hypertension (High Blood Pressure) 10/2020 - 01/2018
2	Obesity 10/2020 - 04/2017
2	Rheumatic Diseases (Rheumatism) 01/2020 - 01/2013
2	Atherosclerosis 01/2018 - 01/2008
2	Neoplasms (Cancer) 01/2018 - 01/2013
1	Weight Loss (Weight Reduction) 11/2022
1	Fatigue 11/2022
1	Acute Coronary Syndrome 01/2022
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021
1	Spondylarthropathies 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Psoriatic Arthritis 01/2021
1	Systemic Vasculitis 01/2021
1	Dyslipidemias (Dyslipidemia) 10/2020
1	Diabetes Mellitus 10/2020
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2020
1	Synovitis 10/2019
1	Gout 01/2018
1	Overweight 04/2017
1	Granuloma 01/2016
1	Headache (Headaches) 01/2016
1	Muscle Weakness 10/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2015
1	Ankylosing Spondylitis 05/2015
1	Anterior Uveitis 05/2015
1	Vascular Diseases (Vascular Disease) 02/2006
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2006
1	Bone Resorption 01/2006
1	Felty Syndrome (Syndrome, Felty's) 01/2005
1	Sepsis (Septicemia) 09/2004
1	Lung Diseases (Lung Disease) 05/2004

Drug/Important Bio-Agent (IBA)

10	Tumor Necrosis Factor InhibitorsIBA 01/2018 - 05/2004
4	Antirheumatic Agents (DMARD)IBA 11/2022 - 01/2021
4	AutoantibodiesIBA 01/2022 - 03/2011
4	Biological ProductsIBA 01/2022 - 01/2017
4	AntibodiesIBA 01/2021 - 01/2009
4	Rheumatoid FactorIBA 01/2021 - 02/2006
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 05/2004
3	Biomarkers (Surrogate Marker)IBA 11/2022 - 12/2013
3	Anti-Citrullinated Protein AntibodiesIBA 01/2021 - 10/2019
3	CholesterolIBA 01/2021 - 10/2015
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2015
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
3	Adalimumab (Humira)FDA Link 01/2018 - 11/2014
3	HLA-DRB1 Chains (HLA DRB1)IBA 09/2006 - 01/2005
2	Peptides (Polypeptides)IBA 01/2021 - 01/2009
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2020
2	GlucocorticoidsIBA 01/2020 - 01/2016
2	Abatacept (Orencia)FDA Link 01/2020 - 04/2017
2	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 05/2004
2	C-Reactive ProteinIBA 10/2019 - 01/2016
2	Hormones (Hormone)IBA 10/2015 - 03/2012
1	Interleukin-6 (Interleukin 6)IBA 11/2022
1	Janus Kinase InhibitorsIBA 12/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021
1	acetyl 4-aminosalicylic acidIBA 01/2021
1	DiureticsIBA 10/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	ametantrone (HAQ)IBA 01/2020
1	HDL CholesterolIBA 01/2018
1	Lipoproteins (Lipoprotein)IBA 01/2018
1	LipidsIBA 01/2018
1	Uric Acid (Urate)IBA 01/2018
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 10/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2015
1	Testosterone (Sustanon)FDA Link 03/2014
1	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2014
1	VimentinIBA 12/2013
1	HLA-C Antigens (HLA-C)IBA 09/2006
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2006
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2005
1	EpitopesIBA 01/2005
1	HLA-DRB1*04:01 antigenIBA 01/2005
1	HLA-DRB1*04 antigenIBA 01/2005
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2004
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2004
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2004
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2004

Therapy/Procedure

7	Therapeutics 01/2021 - 05/2004
1	Critical Care (Surgical Intensive Care) 01/2021
1	Remission Induction 01/2020
1	Ambulatory Care (Outpatient Care) 01/2018
1	Duration of Therapy 01/2016
1	Immunomodulation 01/2013
1	Hip Replacement Arthroplasty (Total Hip Replacement) 04/2011